Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 175,071 | 58,463 | 40,403 | 106,117 |
| Marketable Securities | N/A | 421,695 | 794,865 | 614,580 | 481,645 |
| Receivables | N/A | 343,296 | 310,888 | 391,791 | 395,522 |
| Inventories | 213,290 | 253,361 | 198,571 | 193,787 | 261,046 |
| Other current assets | 141,310 | 70,901 | 142,506 | 122,951 | 124,994 |
| TOTAL | $354,600 | $1,264,324 | $1,505,293 | $1,363,512 | $1,369,324 |
| Non-Current Assets | |||||
| PPE Net | 271,870 | 320,009 | 364,599 | 423,749 | 476,492 |
| Investments And Advances | 91,870 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 231,180 | 532,970 | 492,590 | 502,980 | 556,000 |
| TOTAL | $594,920 | $852,979 | $857,189 | $926,729 | $1,032,492 |
| Total Assets | $949,520 | $2,076,943 | $2,362,492 | $2,290,249 | $2,401,832 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50,830 | 97,130 | 76,400 | 83,710 | 70,440 |
| Accrued Expenses | 109,170 | 176,300 | 185,250 | 170,270 | 110,050 |
| Other current liabilities | 14,780 | 52,250 | 41,350 | 68,710 | 125,730 |
| TOTAL | $305,200 | $319,216 | $353,835 | $344,344 | $324,030 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 143,267 | 127,862 | 124,858 | 161,103 |
| Other Non-Current Liabilities | 85,520 | 75,380 | 38,550 | 41,760 | 54,860 |
| TOTAL | $85,520 | $218,647 | $166,412 | $166,618 | $215,963 |
| Total Liabilities | $390,720 | $547,856 | $527,787 | $510,966 | $539,998 |
| Shareholders' Equity | |||||
| Common Shares | 1,158,630 | 1,219,530 | 1,393,910 | 1,418,740 | 1,473,820 |
| Retained earnings | N/A | 304,278 | 438,196 | 388,015 | 399,919 |
| Other shareholders' equity | -11,830 | 5,279 | 2,599 | -27,472 | -11,905 |
| TOTAL | $1,146,800 | $1,529,087 | $1,834,705 | $1,779,283 | $1,861,834 |
| Total Liabilities And Equity | $1,537,520 | $2,076,943 | $2,362,492 | $2,290,249 | $2,401,832 |